... відкритий, безкоштовний архів рефератів, курсових, дипломних робіт

ГоловнаБіологія, Зоологія, Аграрна наука → Механізми резистентності пухлинних клітин до цисплатина - Реферат

Механізми резистентності пухлинних клітин до цисплатина - Реферат

tumor chemotherapy. J Neurooncol 1997, 31(1-2): 195-207.
17. Vaisman A, Varchenko M, Said I, Chaney SG. Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity. Cytometry 1997, 27(1): 54-64.
18. NishioK, Saigo N. Effect of cisplatin on cell cycle regulators. Gan To Kagaku Ryoho 1994, 21(3): 289-94.
19. Dimanche-Boitrel MT, Micheau O, Hamman A, Haugg M, Eymin B, Chauffert B, Solary E. Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT 29 human colon carcinoma cells. Int J Cancer 1998, 77(5): 796-802.
20. Gill JS, Mindebank AJ. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest 1998, 101(12): 2842-50.
21. Megyesi J, Safirstein RL, Price PM. Induction of p 21 WAF1?CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998, 101(4): 777-82.
22. Otto AM, Paddenberg R, Schubert S, Mannherz HG. Cell cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin. J Cancer Res Clin Oncol 1996, 122(10): 603-612.
23. Boersma AW, Nooter K, Oostrum RG, Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cells cultures treated with cisplatin. Cytometry 1996, 24(2): 123-130.
24. Ormerod MG, O`Neill C, Robertson D, Helland LR, Harrap KR. Cis-diamminedichloroplatinum (II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 1996, 37(5): 463-471.
25. Uslu R, Jewett A, Bonavida B. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody mediated cytotoxicity and apoptosis. Gynecol Oncol 1996, 62(2): 282-91.
26. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. The CD95(APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997, 57(17): 3823-9.
27. McGahon AJ, Costa Pereira AP, Daly L, Cotter TG. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas(APO-1/CD95) receptor/ligand system. Br J Haematol 1998, 101(3): 539-47.
28. Antoku K, Liu Z, Johnson DE. Inhibition of caspase proteases by CrmA enhances the resistance of human leukemia cells to multiple chemotherapeutic agents. Leukemia 1997, 11(10): 1665-72.
29. Chen Z, Naito M, Mashima T, Tsuruo T. Activation of actin-cleavable interleukin 1 beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 1996, 56(22): 5224-9.
30. Marissen WE, Lloyd RE. Eukariotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol Cell Biol 1998, 18(12): 7565-74.
31. Kraker AJ, Moore CW. Accumulation of cis-diamminedichloroplatinum (II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. Cancer Res 1988; 48: 9-13.
32. Eichholtz-Wirth H, Hietel B. The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro. Br J Cancer 1986; 54: 239-43.
33. Kawai K, Kamatani N, Georges E, Ling V. Identification of a membrane glycoprotein overexpression in murine lymphoma sublines resistant to cis- diamminedichloroplatinum (II). J Biol Chem 1990; 265: 13137-42.
34. Ishikawa T, Wright CD, Ishizuka H. GS-X pump Is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 Cells and downregulated by cell differentiation. J Biol Chem 1994; 269: 29085-93.
35. Goto S, Yoshido K, MoriKawa T, Urata Y, Suzuki K,. Kondo T. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res 1995; 55: 4297-301.
36. Veneroni S, Zaffaroni N, Daidone MG, Benini E, Villa R, Silvestrini R. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. Eur J Cancer 1994; 30A: 1002-7.
37. Jedlitschky G, Leier J, Buchholz U, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996; 56: 988-94.
38. Okuyama T, Maehara Y, Endo K, Baba H, Adachi Y, Kuwano M, Sugimachi K. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 1994; 74: 1230-6.
39. Awasthi S, Sharma R, Singhal SS, Herzog NK, Chaubey M, Awasthi YC. Modulation of cisplatin cytotoxicity by sulphasalazine. Br J Cancer 1994; 70: 190-4.
40. Bongers V, Snow GB, Braakhuis BJM. The role of glutathione S-transferases in head and neck squamous cell carcinogenesis. Eur J Cancer 1995; 31B: 349-54.
41 Minagawa Y, Kigawa J, Ishihara H, Itamochi H, Terakawa N. Synergistic enhancement of cisplatin cytotoxicity by SN-38, an active metabolite of CPT-11, for cisplatin-resistant HeLa cells. Jpn J Cancer Res 1994; 85: 966-71.
42. Boscia RE, Korbut T, Holden SA, Ara G, Teicher BA. Interaction of topoisomerase I inhibitors with radiation in cis-Diamminedichloroplatinum (II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo. Int J Cancer 1993; 53: 118-23.
43. Kikuchi Y, Hirata J, Yamamoto K, Ishi K, Kita T, Kudoh K, Tode T, Nagata I, Taniguchi K, Kuwano M. Altered expression of ?-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells. Jpn J Cancer Res 1997; 88: 213-7.
44. Hirata J, Kikuchi Y, Kita T, Imaizumi EE, Tode T, Ishii K, Kudoh K, Nagata I. Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum (II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-Buthionine-S,R-Sulphoximine. Int J Cancer 1993; 55: 521-7.
45.Sugimoto C, Matsukawa S, Fujieda S, Noda I, Tanaka N, Tsuzuki H, Saito H. Involvement of intracellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line. Anticancer Res 1996; 16: 675-80.
46. Pendyala L, Perez R, Weinstein A, Zdanowicz J, Creaven PJ. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line. Cancer Chemother Pharmacol 1997, 40 (1): 38-44.
47. Kurokawa H, Nishio K, Ishida T, Arioka H, Fukuoka K, Nomoto T, Fukumoto H, Yokote H, Saijo N. Effect of glutathione depletion on cisplatin resistance in cancer cells transfected with the ? -glutamylcysteine synthetase gene. Jpn J Cancer Res 1997; 88: 108-10.
48. Campling BG, Baer K, Baker HM, Lam YM. Cole SPC. Do glutathione and related enzymes